PubRank

P S Sarin

Author PubWeight™ 115.38‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS. Science 1986 5.86
2 Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA. Proc Natl Acad Sci U S A 1986 5.18
3 Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS). Science 1983 4.72
4 Isolation and transmission of human retrovirus (human t-cell leukemia virus). Science 1983 4.67
5 Transformation of human umbilical cord blood T cells by human T-cell leukemia/lymphoma virus. Proc Natl Acad Sci U S A 1983 3.01
6 Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus. Proc Natl Acad Sci U S A 1988 2.98
7 Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides. Proc Natl Acad Sci U S A 1988 2.85
8 The human type-C retrovirus, HTLV, in Blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphoma. Int J Cancer 1982 2.71
9 Terminal deoxynucleotidyl transferase activities in human blood leukocytes and lymphoblast cell lines: high levels in lymphoblast cell lines and in blast cells of some patients with chronic myelogenous leukemia in acute phase. Blood 1976 2.64
10 Viral and cellular DNA polymerase: comparison of activities with synthetic and natural RNA templates. Science 1972 2.53
11 Infection of chimpanzees by human T-lymphotropic retroviruses in brain and other tissues from AIDS patients. Lancet 1985 2.35
12 Epidemiology of human T-cell leukemia/lymphoma virus. J Infect Dis 1983 2.26
13 Reverse transcriptase activity of human acute leukaemic cells: purification of the enzyme, response to AMV 70S RNA, and characterization of the DNA product. Nat New Biol 1972 2.25
14 Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analogues. Proc Natl Acad Sci U S A 1989 2.14
15 HTLV-I and HTLV-III antibodies and tropical spastic paraparesis. Lancet 1985 2.07
16 Inhibition of HTLV-III/LAV replication by foscarnet. Biochem Pharmacol 1985 1.97
17 ELISA HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy Africans. Lancet 1985 1.85
18 Neutralization of HTLV-III/LAV replication by antiserum to thymosin alpha 1. Science 1986 1.75
19 Inhibition of replication of the etiologic agent of acquired immune deficiency syndrome (human T-lymphotropic retrovirus/lymphadenopathy-associated virus) by avarol and avarone. J Natl Cancer Inst 1987 1.73
20 Cholesteryl-conjugated oligonucleotides: synthesis, properties, and activity as inhibitors of replication of human immunodeficiency virus in cell culture. Proc Natl Acad Sci U S A 1989 1.71
21 Lymphokine production by cultured human T cells transformed by human T-cell leukemia-lymphoma virus-I. Science 1984 1.65
22 Anti-viral activity of amphotericin B methyl ester: inhibition of HTLV-III replication in cell culture. Biochem Pharmacol 1986 1.48
23 Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor. J Clin Invest 1984 1.46
24 Effects of a novel compound (AL 721) on HTLV-III infectivity in vitro. N Engl J Med 1985 1.35
25 Terminal deoxynucleotidyltransferase in chronic myelogenous leukemia. J Biol Chem 1974 1.31
26 HTLV-III seropositivity in European haemophiliacs exposed to Factor VIII concentrate imported from the USA. Lancet 1984 1.20
27 Detection of infectious HTLV-III/LAV virus in cell-free plasma from AIDS patients. Lancet 1985 1.19
28 Inactivation of human T-cell lymphotropic retrovirus (HTLV-III) by LD. N Engl J Med 1985 1.13
29 T cell malignancies and human T cell leukemia virus. Semin Oncol 1984 1.10
30 Conformational differences between s-RNA and aminoacyl s-RNA. Biochem Biophys Res Commun 1965 1.09
31 Human immunodeficiency virus contains an epitope immunoreactive with thymosin alpha 1 and the 30-amino acid synthetic p17 group-specific antigen peptide HGP-30. Proc Natl Acad Sci U S A 1987 1.07
32 Utilization of mammalian 70S RNA by a purified reverse transcriptase from human myelocytic leukemic cells. Biochem Biophys Res Commun 1973 1.07
33 HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individuals. Proc Natl Acad Sci U S A 1990 1.05
34 Regional variation in prevalence of antibody against human T-lymphotropic virus types I and III in Kenya, East Africa. Int J Cancer 1985 1.04
35 Production of 1,25-dihydroxyvitamin D3 by human T cell lymphotrophic virus-I-transformed lymphocytes. J Clin Invest 1986 1.03
36 Inhibition of HIV replication by liposomal encapsulated amphotericin B. Antiviral Res 1989 1.01
37 Anal intercourse as a possible factor in heterosexual transmission of HTLV-III to spouses of hemophiliacs. N Engl J Med 1985 1.01
38 Terminal transferase in human bone-marrow lymphocytes. Lancet 1976 0.98
39 Purification and characterization of baboon endogenous virus DNA polymerase. Biochim Biophys Acta 1977 0.96
40 Transmission experiments with human T-lymphotropic retroviruses and human AIDS tissue. Lancet 1984 0.96
41 Human immunodeficiency virus infection of the developing human nervous system. Virology 1987 0.94
42 High incidence of human type-C retrovirus (HTLV) in family members of a HTLV-positive Japanese T-cell leukemia patient. Proc Natl Acad Sci U S A 1983 0.91
43 Conformational differences among purified samples of transfer RNA from yeast. Proc Natl Acad Sci U S A 1966 0.90
44 Properties of noninfectious and transforming viruses released by Murine sarcoma virus-induced hamster tumor cells. J Virol 1973 0.89
45 Inhibition of HIV replication by Hyssop officinalis extracts. Antiviral Res 1990 0.89
46 Human T-lymphotropic retroviruses in adult T-cell leukemia-lymphoma and acquired immune deficiency syndrome. J Clin Immunol 1984 0.88
47 Effect of structural variations in cholesteryl-conjugated oligonucleotides on inhibitory activity toward HIV-1. Bioconjug Chem 1992 0.87
48 Immune response and epitope mapping of a candidate HIV-1 p17 vaccine HGP30. J Clin Lab Anal 1990 0.87
49 Antibiotics of the ostreogrycin complex. II. Structure of ostreogrycin A. J Chem Soc Perkin 1 1966 0.87
50 Repairing the T-cell defect in AIDS. Lancet 1985 0.86
51 Induction of cross clade reactive specific antibodies in mice by conjugates of HGP-30 (peptide analog of HIV-1(SF2) p17) and peptide segments of human beta-2-microglobulin or MHC II beta chain. Vaccine 2001 0.86
52 Prolonged antiviral activity of D-penicillamine in human immunodeficiency virus-infected homosexual men. Am J Med 1987 0.86
53 The relationship of abnormalities of cellular immunity to antibodies to HTLV-III in homosexual men. Cell Immunol 1986 0.86
54 Human T-cell leukemia/lymphoma virus: the retrovirus of adult T-cell leukemia/lymphoma. J Infect Dis 1983 0.85
55 Constitutive production and release of a lymphokine with macrophage-activating factor activity distinct from gamma-interferon by a human T-cell leukemia virus-positive cell line. Cancer Res 1984 0.83
56 Synthesis and anti-HIV activity of oligoribonucleotides and their phosphorothioate analogs. Ann N Y Acad Sci 1992 0.83
57 Neutralizing antibodies as a prognostic indicator in the progression of acquired immune deficiency syndrome (AIDS)-related disorders: a double-blind study. J Clin Immunol 1988 0.82
58 Genomic diversity of Zairian HIV isolates: biological characteristics and clinical manifestation of HIV infection. AIDS Res Hum Retroviruses 1987 0.81
59 In-vitro inhibition of LAV/HTLV-III infected lymphocytes by dithiocarb and inosine pranobex. Lancet 1986 0.81
60 Specific antibody responses to synthetic peptides of HIV-1 p17 correlate with different stages of HIV-1 infection. J Acquir Immune Defic Syndr 1992 0.81
61 Inverse relationship between HIV-1 p24 antigenemia, anti-p24 antibody and neutralizing antibody response in all stages of HIV-1 infection. Immunol Lett 1989 0.80
62 Chromatin conformation during cell differentiation of human myeloid leukemia cells. Cancer Lett 1979 0.79
63 Differential modulation of host cell and HIV gene expression by combinations of avarol and AZT in vitro. Biochem Pharmacol 1988 0.78
64 Characterization of terminal deoxynucleotidyltransferase in a cell line (8402) derived from a patient with acute lymphoblastic leukemia. Biochem Biophys Res Commun 1975 0.78
65 Lack of evidence for retrovirus infection in schizophrenic patients. Br J Psychiatry 1985 0.78
66 HIV-1 expression by T8 lymphocytes after transfection. AIDS Res Hum Retroviruses 1988 0.78
67 Inhibition of expression of natural UAG suppressor glutamine tRNA in HIV-infected human H9 cells in vitro by Avarol. AIDS Res Hum Retroviruses 1988 0.78
68 Flt3 ligand enhances the immunogenicity of a gag-based HIV-1 vaccine. Int J Immunopharmacol 2000 0.78
69 Transcription of heteropolymeric regions of avian myeloblastosis virus high molecular weight RNA with Escherichia coli DNA polymerase I. Biochem Biophys Res Commun 1974 0.77
70 Comparison of biochemical characteristics of reverse transcriptase from human acute leukemic cells and several RNA tumor viruses. Basic Life Sci 1974 0.77
71 Reverse transcriptase in type C virus particles of human origin. Nat New Biol 1971 0.77
72 Differential in vitro anti-HIV activity of natural lignans. Z Naturforsch C 1991 0.77
73 Detection of the histone-2A related polypeptide in differentiated human myeloid cells (HL-60) and its distribution in human acute leukemia. Int J Cancer 1981 0.77
74 Karyotypic differences between primary cultures and cell lines from tumors with the human T-cell leukemia virus. J Natl Cancer Inst 1984 0.77
75 Antibiotics of the ostreogrycin complex. IV. The structure of ostreogrycin G. J Chem Soc Perkin 1 1966 0.76
76 The structure of ostreogrycin A. Tetrahedron Lett 1966 0.76
77 Human T-cell leukemia-lymphoma virus (HTLV). Prog Hematol 1983 0.76
78 Human T-cell growth factor (TCGF). Crit Rev Immunol 1984 0.76
79 Loss of terminal deoxynucleotidyl transferase (TdT) activity as a predictor of emergence of resistance to chemotherapy in a case of chronic myelogenous leukemia in blast crisis. Cancer 1979 0.76
80 Lipid conjugates of antiretroviral agents. II. Disodium palmityl phosphonoformate: anti-HIV activity, physical properties, and interaction with plasma proteins. Biochem Biophys Res Commun 1990 0.75
81 Inhibition of HIV replication by naphthalenemonosulfonic acid derivatives and a bis naphthalenedisulfonic acid compound. Life Sci 1990 0.75
82 Selective inhibition of replication of the AIDS-associated virus HTLV-III/LAV by synthetic D-penicillamine. Arzneimittelforschung 1986 0.75
83 CD4-modified synthetic peptides containing phenylalanine inhibit HIV-1 infection in vitro. J Acquir Immune Defic Syndr 1994 0.75
84 Evidence for HTLV-III in T-cells from semen of AIDS patients: expression in primary cell culture, long-term mitogen-stimulated cell cultures, and cocultures with a permissive T-cell line. Cancer Res 1985 0.75
85 Evidence for HTLV-III/LAV expression by primary cultures of T8 cells. Int J Cancer 1986 0.75
86 Enrichment of terminal deoxynucleotidyl transferase activity by cell separation. Adv Exp Med Biol 1982 0.75
87 Enrichment of cell populations containing terminal deoxynucleotidyl transferase activity by free flow electrophoresis. Int J Cancer 1982 0.75
88 Marrow terminal deoxynucleotidyl transferase activity in adult acute leukemia. Haematol Blood Transfus 1979 0.75
89 Early relapse of acute lymphoblastic leukemia is not predictable by serial biochemical assays of terminal transferase activity in cells from peripheral blood. Leuk Res 1984 0.75
90 Terminal deoxynucleotidyl transferase as a biological marker for human leukemia. Hamatol Bluttransfus 1976 0.75
91 T cell proliferation and human T cell leukemia virus (HTLV). Prog Clin Biol Res 1983 0.75
92 Cellular transformation by human T cell leukemia retroviruses (HTLV). Pharmacol Ther 1985 0.75
93 Retroviruses in human T-cell malignancies. Cancer Invest 1984 0.75
94 Inhibition of HIV replication by derivatives of naphthalenedisulfonic acids. AIDS 1990 0.75
95 Terminal transferase in acute lymphoblastic leukemia in gibbons. Biochim Biophys Acta 1980 0.75
96 Biochemical approaches to detection of viral related information in human acute leukemic cells. Bibl Haematol 1975 0.75
97 Detection of human T-cell leukemia virus antibodies in a Japanese T-cell leukemia patient with hypercalcemia. Cancer 1984 0.75
98 T cell malignancies and human T cell leukemia (lymphotropic) retroviruses (HTLV). Prog Clin Biol Res 1985 0.75
99 Characterization of an RNA-directed DNA-polymerase from a cell line derived from a radiation-induced lymphoma in mice. Biochim Biophys Acta 1979 0.75
100 Lipid conjugates of antiretroviral agents. I. Azidothymidine-monophosphate-diglyceride: anti-HIV activity, physical properties, and interaction with plasma proteins. Biochem Biophys Res Commun 1990 0.75
101 Proceedings: Distribution of the RNA dependent DNA polymerase in human acute leukemic cells. Proc Natl Cancer Conf 1972 0.75
102 High expression of multinucleated giant cells in cultures of peripheral blood cells from HIV infected patients. Haematologica 1990 0.75
103 Genetic mutations and abnormal hemoglobins. Curr Mod Biol 1968 0.75
104 Cross-clade p17 peptide recognition by antisera to HGP-30, a 30-amino acid synthetic peptide antigen from HIV type 1 p17. AIDS Res Hum Retroviruses 1998 0.75
105 Biochemical properties of reverse transcriptase activities from human cells and RNA tumor viruses. Johns Hopkins Med J Suppl 1973 0.75
106 Dual biological activity of apurinic acid on human lymphocytes: induction of interferon-gamma and protection from human immunodeficiency virus infection in vitro. Antiviral Res 1988 0.75
107 A phase I study of HGP-30, a 30 amino acid subunit of the human immunodeficiency virus (HIV) p17 synthetic peptide analogue sub-unit vaccine in seronegative subjects. AIDS Res Hum Retroviruses 1992 0.75
108 The intracellular location of terminal transferase does not vary with cell cycle stage. Leuk Res 1984 0.75
109 Purification and characterization of gibbon ape leukemia virus DNA polymerase. Biochim Biophys Acta 1976 0.75
110 U.V. induced conformational changes in transfer RNA. Photochem Photobiol 1968 0.75
111 Epitope mapping of the low-molecular-mass subunits of reverse transcriptase in human immunodeficiency virus type 1 by monoclonal antibodies. Biomed Sci 1990 0.75
112 Inhibition of tat-mediated HIV-1-LTR transactivation and virus replication by sulfhydryl compounds with chelating properties. Anticancer Res 2000 0.75
113 Cell-mediated immunity against HGP-30, a group-specific peptide of HIV p17 in individuals infected with the AIDS virus. Biomed Pharmacother 1992 0.75
114 Inactivation of human immunodeficiency virus (HIV) by ionizing radiation in body fluids and serological evidence. J Forensic Sci 1989 0.75
115 Enzyme-linked immunosorbent assay quantification of cytokine concentrations in human meningiomas. Neurosurgery 1996 0.75
116 Transmission of human T-cell leukemia virus (HTLV) into human cord blood T cells. Haematol Blood Transfus 1983 0.75